SCHEMBL531502

SCHEMBL531502

CC=CCCCCCCCCCCCCCCCCC[O]

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 4/20 0.37
TRPV1 Q8NER1 1/20 0.37
TERT O14746 3/20 0.37
PTPN1 P18031 3/20 0.37
PPARG P37231 3/20 0.37
PPARD Q03181 3/20 0.37
PPARA Q07869 3/20 0.37
CYP1A2 P05177 2/20 0.37
MAPT P10636 2/20 0.37
CYP2C19 P33261 2/20 0.37
BLM P54132 2/20 0.37
HSD17B10 Q99714 2/20 0.37
FABP4 P15090 2/20 0.37
F7 P08709 2/20 0.37
F3 P13726 2/20 0.37
KMT2A Q03164 2/20 0.37
SOAT1 P35610 2/20 0.37
TOP1 P11387 2/20 0.37
GMNN O75496 1/20 0.37
USP2 O75604 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL531501 1.00 FAAH (0.37) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL5170033 1.00 FAAH (0.37) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL9508599 1.00 FAAH (0.37) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL9507523 1.00 FAAH (0.37) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL5407889 1.00 FAAH (0.37) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL5168332 1.00
SCHEMBL5170043 1.00 FAAH (0.37) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL5170038 1.00 FAAH (0.37) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL5404449 1.00 FAAH (0.37) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL5170050 1.00 FAAH (0.37) FAAHTRPV1TERTPTPN1PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1854877-B1 Process for the deacylation of cyclic lipopeptides ASTELLAS PHARMA INC (JP) 2012-02-08 EP disclosed
EP-2172546-A1 Process for the deacylation of cyclic lipopeptides Astellas Pharma Inc. (JP) 2010-04-07 EP disclosed
EP-0885957-B1 PROCESS FOR THE DEACYLATION OF CYCLIC LIPOPEPTIDES ASTELLAS PHARMA INC (JP) 2009-08-12 EP disclosed
EP-1854877-A2 Process for the deacylation of cyclic lipopeptides Astellas Pharma Inc. (JP) 2007-11-14 EP disclosed
EP-1666587-A1 Cyclic lipopeptide acylase Astellas Pharma Inc. (JP) 2006-06-07 EP disclosed
US-6825003-B2 Cyclic lipopeptide acylase FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-11-30 US disclosed
US-6573084-B1 Culture of Streptomyces anulatus 4811 (FERM BP-5808); deacylation of the lipid acyl moiety of FR-901379, Echinocandin B, and Aculeacin A FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-06-03 US disclosed
US-6537789-B1 Using isolated acylase enzyme obtained from Streptomyces FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-03-25 US disclosed
US-20020115133-A1 Cyclic lipopeptide acylase FUJISAWA PHARMACEUTICAL CO. LTD. (JP) 2002-08-22 US disclosed
US-6399567-B1 POLYPEPTIDE FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-06-04 US disclosed
WO-1998022498-A1 CYCLIC HEXAPEPTIDES HAVING ANTIBIOTIC ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-05-28 WO disclosed
US-5693750-A MICROBIOCIDAL ACTION AGAINST PNEUMOCYSTIS INFECTIONS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-12-02 US disclosed
US-H1638-H CYCLIC HEXAPEPTIDE FURUTA TAKAHISA (JP) 1997-03-04 US disclosed
US-5569646-A TREATMENT OF PNEUMONIA; MICROBIOCIDES, FUNGICIDES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-10-29 US disclosed
EP-0462531-B1 Cyclic polypeptide with antibiotic activity, process for its preparation and pure culture of a Coelomycetes strain FUJISAWA PHARMACEUTICAL CO (JP) 1996-10-02 EP disclosed
EP-0729974-A1 Cyclic polypeptide with antibiotic activity and a process for preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-09-04 EP disclosed
EP-0644199-A1 Cyclic antimicrobial peptides and preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1995-03-22 EP disclosed
US-5376634-A Microbiocides FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-12-27 US disclosed
EP-0486011-A2 Pharmaceutical composition against Pneumocystis carinii FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-05-20 EP disclosed
EP-0462531-A2 Cyclic polypeptide with antibiotic activity, process for its preparation and pure culture of a Coelomycetes strain FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1991-12-27 EP disclosed